Validity and Reliability of the U.S. National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

IMPORTANCE: Symptomatic adverse events (AEs) in cancer trials are currently reported by clinicians using the National Cancer Institute's (NCI) Common Terminology Criteria for Adverse Events (CTCAE). To integrate the patient perspective, the NCI developed a patient-reported outcomes version of t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JAMA Oncol
Hlavní autoři: Dueck, Amylou C., Mendoza, Tito R., Mitchell, Sandra A., Reeve, Bryce B., Castro, Kathleen M., Rogak, Lauren J., Atkinson, Thomas M., Bennett, Antonia V., Denicoff, Andrea M., O'Mara, Ann M., Li, Yuelin, Clauser, Steven B., Bryant, Donna M., Bearden, James D., Gillis, Theresa A., Harness, Jay K., Siegel, Robert D., Paul, Diane B., Cleeland, Charles S., Schrag, Deborah, Sloan, Jeff A., Abernethy, Amy P., Bruner, Deborah W., Minasian, Lori M., Basch, Ethan
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4857599/
https://ncbi.nlm.nih.gov/pubmed/26270597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2015.2639
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky